The EsophyX2 HD received FDA 510(k) clearance in September. The new product is designed to offer physicians use a larger range of endoscopes when performing transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease.
“Now, physicians with either traditional scopes or the latest endoscopic imaging technology may choose the scientifically proven TIF procedure for select patients,” said EndoGastric Solutions President and CEO Skip Baldino.
More articles on gastroenterology:
23 GI-driven ASCs & facilities opened or announced in 2014
Physicians vs. computers: Who creates better patient reports?
8 gastroenterologist moves & honors
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
